J&J Strikes $6.5 Billion Deal for Autoimmune Disease Specialist Momenta

Johnson & Johnson on Wednesday agreed to pay about $6.5 billion in cash to buy Momenta Pharmaceuticals Inc in a deal aimed at expanding its portfolio of autoimmune disease treatments.

The deal gives J&J’s Janssen unit access to Momenta’s experimental therapy, nipocalimab, being tested for myasthenia gravis, a neuromuscular disease that causes weakness in muscles, and other diseases where the immune system attacks the body.

J&J hopes to get the drug approved to treat several conditions and eventually bring in blockbuster sales, as the company bulks up its pharmaceuticals unit, its largest business.

Shares of Cambridge, Massachusetts-based Momenta were up 69.3% at $52.15 before the bell, just a hair’s breadth away from the offer price of $52.50.

“Janssen will have the potential to introduce multiple launches, many as first-in-class indications with potential for significant peak year sales, some of which could exceed $1 billion,” Johnson & Johnson said in a statement.

In the past two years, the healthcare conglomerate has unloaded some divisions that manufacture medical devices for diabetes care and has also been aiming to bolster its presence in fast-growing markets such as cancer.

Nipocalimab is being developed to treat diseases where the body’s own antibodies attack or damage proteins and cells.

The deal comes just days after France’s Sanofi struck a $3.7 billion deal to buy Principia Biopharma Inc for its pipeline of autoimmune disease treatments.

Johnson & Johnson said an estimated 2.5% of the global population have some type of autoantibody-driven disease, many of which are rare diseases.

Its drug Stelara targets an autoimmune disease called psoriatic arthritis.

Also Watch

Sushant’s Father Issues Statement, Says No One Can Claim Rights Over SSR’s Estate | CNN News18

J&J, which is also one of the drugmakers racing to develop a vaccine for the coronavirus, has recently signed deals with the United States and Britain for future doses of the vaccine.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor


Array
(
[videos] => Array
(
[0] => Array
(
[id] => 5f3d1621082aa874143e2b11
[youtube_id] => HpoPfcKdFSo
J&J Strikes $6.5 Billion Deal for Autoimmune Disease Specialist Momenta => Sushant’s Father Issues Statement, Says No One Can Claim Rights Over SSR’s Estate | CNN News18
)

[1] => Array
(
[id] => 5f3d1531ebd3817406537085
[youtube_id] => DOhyrYb_Tzc
J&J Strikes $6.5 Billion Deal for Autoimmune Disease Specialist Momenta => Monsoon Mayhem: IMD Issues Orange Alert For Next 3 Days As Heavy Rains Lash Parts Of Delhi-NCR
)

)

[query] => https://pubstack.nw18.com/pubsync/v1/api/videos/recommended?source=n18english&channels=5d95e6c378c2f2492e2148a2,5d95e6c278c2f2492e214884,5d96f74de3f5f312274ca307&categories=5d95e6d7340a9e4981b2e10a&publish_min=2020-08-16T17:40:02.000Z&publish_max=2020-08-19T17:40:02.000Z&sort_by=date-relevance&order_by=0&limit=2
)

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

The Disease That Could Topple Traditional Higher Education

Photographer Dimas Ardian/Bloomberg © 2020 Bloomberg Finance...

Council Post: How To Make Your Virtual Company Party...

Michael Saulpaugh is a Managing Partner at Montclair, NJ based Elegant Music Group. ...

Williams F1 Team Already Fully Funded Into 2021

The Williams F1 team is on track to get...

Gold Prices Today, February 17, 2021: Gold prices fall...

New Delhi: Gold in the national capital plunged Rs 717 to Rs 46,102 per...